Testing virtual reality for age-related macular degeneration
Part of Eyes & vision clinical trials.
This study uses virtual reality tests to see if they can measure vision changes in people with age-related macular degeneration (AMD), a condition that affects central vision. It compares results from healthy volunteers and people at different stages of AMD.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 50 years or older
- You can speak and understand French well enough for the tests
- You have no other major eye disease like glaucoma or cataracts in the study eye
- You are not taking certain medications that affect balance, vision, or thinking
- You are not pregnant or breastfeeding
- You can give your own consent and follow the study rules
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special vision test called microperimetry to track how well the macula (the center of the retina) works in people with certain eye conditions like geographic atrophy or diabetic eye disease. Healthy volunteers are also needed for comparison. The goal is to understand how these conditions affect retinal function over time.
This study tests a new way to measure vision, called MLSDT, in people with normal sight or vision loss from Stargardt disease or geographic atrophy (a type of advanced age-related macular degeneration). Results will help doctors better understand how well patients can see.
This trial uses artificial intelligence to track changes in the eyes of people with advanced age-related macular degeneration (AMD) that has caused a specific type of damage (atrophy) in the retina. The goal is to see if AI can help detect when the disease gets worse, so doctors can personalize monitoring for each patient.
This study uses specialized eye imaging to track changes in geographic atrophy, a type of vision loss from macular degeneration. Researchers will use new imaging techniques to better understand how this condition progresses and how treatments work.
This study tests a quick, noninvasive eye test that measures how well you see in the dark, which can be an early sign of dry AMD. Researchers want to see if the test relates to everyday tasks like reading or driving at night.
This study looks at how well the eyes function in people with early or intermediate age-related macular degeneration (AMD). It uses imaging and vision tests to help doctors better understand the condition.
Hear when a new Geographic Atrophy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.